BioGaia Gastrus Probiotic

BioGaia® Gastrus® Probiotic

Lactobacillus reuteri (DSM 17938 + ATCC PTA 6475) 200 million organisms (CFU)

Targeted support with this unique Lactobacillus reuteri strain combination

Clinically trialed probiotic combination

• Contains only probiotic strains of human origin: Lactobacillus reuteri DSM 17938 + Lactobacillus reuteri ATCC PTA 6475 (both strains isolated from breast milk)
• Provides evidence-based probiotic strains with clinical data to support their use
• Delivers probiotic strains that survive transit through gastrointestinal (GI) tract without significant loss of potency (CFSs)
• Contains two probiotic strains shown to colonise the GI tract and adhere strongly to mucosal layer
• Delivers a scientifically validated daily dose of 200 million organisms (CFSs) in a convenient one-a-day dose
• Does not require refrigeration, for ease of use and dispensing

Active Ingredients / Formulation

Each chewable tablet contains:
Lactobacillus reuteri (DSM 17938)……………………………100Mill*
Lactobacillus reuteri (ATCC PTA 6475)……………………..100Mill*

*CFU = Colony-Forming Units of Live Bacteria

Directions

Adults and children

• Take 1 chewable tablet daily, with or without food, or as directed by your prescribing healthcare practitioner.

Ingredients (Protectis Chewable Tablets)

Ingredients: Lactobacillus reuteri DSM 17938, Lactobacillus reuteri ATCC PTA 6475, isomalt, hydrogenated palm oil, ascorbic acid, mandarin flavour, mint flavour.

No Added: 

Wheat | Yeast | Soy | Dairy | Animal products | Lactose | Egg | Nuts | Artificial colours, flavours, or preservatives.

Suitable for vegetarians and vegans.

Disclaimer

For practitioner dispensing only.

Always read the label. Follow the directions for use.

Note Limosilactobacillus reuteri  is a synonym for Lactobacillus reuteri